McKinsey January 31, 2023
Bjorn Albrecht, Siméone de Fremond, Thomas Devenyns, Richard Ting Li, Dan Tinkoff, and Lieven Van der Veken

Life sciences companies are making progress in adopting and deploying digital and analytics. But they can go further and faster by heeding some lessons from the past few years.

Looking toward the new year is a good time to take stock of the life sciences industry’s digital maturity. This article provides ten observations from McKinsey’s work in this space, complemented by targeted analyses and a McKinsey survey conducted in November 2022 of one hundred digital and analytics (DnA) leaders in life sciences functional areas, such as R&D, manufacturing and supply chain (M&SC), commercial, and enabling functions such as finance and HR.1 Life sciences companies have historically lagged behind banking, telecom, retail, and other industries in digital maturity. A McKinsey analysis...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Analytics, Biotechnology, Digital Health, Pharma / Biotech, Technology, Trends
Related Articles:
GLP1 Drugs Not Tied to Pregnancy Loss, Birth Defects
FDA advisers to weigh first psychedelic therapy in early June
Verve moves forward with backup base editing therapy
STAT+: Young boy dies in trial for Pfizer Duchenne gene therapy
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply

Share This Article